MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Contract SPE2DP22F2903 is a delivery order issued by the Defense Logistics Agency under the primary contract SPE2DX15D9383 to DMS Pharmaceutical Group Inc. The award, posted on August 25, 2026, was specifically for the procurement of Meloxicam Tablets under NSN 6505015413243. While the overarching commercial items contract SPE2DX15D9383 carries a total award value of 4,999,999.00 dollars, this specific delivery order was subject to subsequent administrative changes. Modification P00001 resulted in the total cancellation of CLIN 0001 for this order, reducing the contract value to 0.00 dollars. This termination for the government's convenience was executed by DLA Troop Support due to the decommissioning of ships and the presence of aged orders. The action decreased the order value by 6.02 dollars, effectively nullifying the requirement for the Meloxicam Tablets.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
